Tim Bingham || E-mail: info@timbingham.ie || Mob.: +353863893530

Category Archive for ‘Resources’

New psychoactive substances (NPS): Building knowledge and evidence based training through research

  Taking into account the broader picture regarding NPS, along with the absence of relevant information regarding the prevalence of use of NPS, among young

Read More

Drug Consumption Rooms can be utilised successfully in Ireland. Is Ireland ready for them?

   Drug Consumption Rooms can  be utilised successfully in Ireland. Is Ireland ready for them?’  I was recently going through some old files and came

Read More

Bold new laws introduced in Ireland to tackle legal highs and NPS dramatically cut the number of head shops. But the country’s drug users switched substances or modes of supply

  This article  which I wrote appeared in March 2014  Druglink magazine. Druglink is a bi-monthly magazine for all those UK professionals interested in drugs

Read More

Australian use of underground illicit drug websites jumps

The number of illicit drug retailers selling to Australia on underground websites such as the now defunct Silk Road increased significantly in 2013, according to

Read More

EMCDDA–Europol Joint Report on a new psychoactive substance: 5-IT

Article 5.1 of Council Decision 2005/387/JHA (1) (hereinafter referred to as the ‘Decision’) stipulates that ‘Where Europol and the EMCDDA, or the Council, acting by a

Read More

Is the breast cancer drug tamoxifen being sold as a bodybuilding dietary supplement?

For more than 30 years, bodybuilders have taken tamoxifen to prevent and treat gynaecomastia caused by use of anabolic steroids. Usually, tamoxifen is sourced from the

Read More

EMCDDA–Europol Joint report on a new psychoactive substance: AH-7921

The EMCDDA–Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1 (dimethylamino)cyclohexyl]methyl]benzamide), submitted in December 2013 to the Council of the EU, the European Commission and

Read More

EMCDDA–Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)

The EMCDDA–Europol Joint Report on new psychoactive substance (3,4-methylenedioxypyrovalerone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA.

Read More
Back to Top